Financial reports
10-K
2023 FY
Annual report
8 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Departure of Directors or Certain Officers
19 Mar 24
8-K
Departure of Directors or Certain Officers
15 Mar 24
8-K
Ainos Reports Full Year 2023 Financial Results
8 Mar 24
8-K
Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation
5 Feb 24
8-K
Ainos Announces $1.75 Million Follow On Funding
25 Jan 24
8-K
Entry into a Material Definitive Agreement
12 Jan 24
8-K
Other Events
2 Jan 24
8-K
Other Events
22 Dec 23
8-K
Amendments to Articles of Incorporation or Bylaws
14 Dec 23
8-K
Ainos,Inc. Announces Stock Consolidation
12 Dec 23
Registration and prospectus
S-1
IPO registration
8 Apr 24
S-1/A
IPO registration (amended)
15 Dec 23
S-1
IPO registration
8 Dec 23
S-8
Registration of securities for employees
14 Jun 23
424B4
Prospectus supplement with pricing info
10 Aug 22
S-1/A
IPO registration (amended)
2 Aug 22
8-A12B
Registration of securities on exchange
1 Aug 22
S-1/A
IPO registration (amended)
27 Jul 22
S-1/A
IPO registration (amended)
22 Jul 22
S-1/A
IPO registration (amended)
8 Jul 22
Proxies
DEFA14A
Additional proxy soliciting materials
27 Oct 23
DEF 14A
Definitive proxy
27 Oct 23
DEF 14C
Information statement
27 Oct 23
PRE 14C
Preliminary information
16 Oct 23
DEF 14C
Information statement
4 Apr 23
PRE 14C
Preliminary information
7 Mar 23
DEF 14C
Information statement
31 May 22
PRE 14C
Preliminary information
18 May 22
DEF 14C
Information statement
19 Mar 21
PRE 14C
Preliminary information
28 Jan 21
Other
EFFECT
Notice of effectiveness
17 Apr 24
EFFECT
Notice of effectiveness
19 Dec 23
CORRESP
Correspondence with SEC
14 Dec 23
UPLOAD
Letter from SEC
14 Dec 23
EFFECT
Notice of effectiveness
9 Aug 22
CERT
Certification of approval for exchange listing
8 Aug 22
CORRESP
Correspondence with SEC
4 Aug 22
CORRESP
Correspondence with SEC
4 Aug 22
CORRESP
Correspondence with SEC
4 Aug 22
CORRESP
Correspondence with SEC
2 Aug 22